Ordinary Adjustment | Julius Baer Next Generation Healthy China Index | Effective Date 8th July 2024
Julius Baer Next Generation Healthy China Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th July 2024:
3SBIO INC |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD |
BEIGENE LTD |
CHINA MEDICAL SYSTEM HOLDINGS LTD |
CHINA RESOURCES PHARMACEUTICAL |
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD |
CSPC PHARMACEUTICAL GROUP LTD |
HANSOH PHARMACEUTICAL GROUP CO |
HUTCHMED CHINA LTD |
INNOVENT BIOLOGICS INC |
JD HEALTH INTERNATIONAL INC |
PING AN HEALTHCARE AND TECHNOL |
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H |
SINO BIOPHARMACEUTICAL LTD ORD |
SINOPHARM GROUP CO LTD |
WUXI APPTEC CO LTD |
WUXI BIOLOGICS CAYMAN INC |
ZAI LAB LTD |